1. Home
  2. RFL vs BAFN Comparison

RFL vs BAFN Comparison

Compare RFL & BAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • BAFN
  • Stock Information
  • Founded
  • RFL 2017
  • BAFN 1999
  • Country
  • RFL United States
  • BAFN United States
  • Employees
  • RFL N/A
  • BAFN N/A
  • Industry
  • RFL Real Estate
  • BAFN Savings Institutions
  • Sector
  • RFL Finance
  • BAFN Finance
  • Exchange
  • RFL Nasdaq
  • BAFN Nasdaq
  • Market Cap
  • RFL 65.4M
  • BAFN 55.4M
  • IPO Year
  • RFL N/A
  • BAFN N/A
  • Fundamental
  • Price
  • RFL $2.01
  • BAFN $13.75
  • Analyst Decision
  • RFL
  • BAFN
  • Analyst Count
  • RFL 0
  • BAFN 0
  • Target Price
  • RFL N/A
  • BAFN N/A
  • AVG Volume (30 Days)
  • RFL 41.9K
  • BAFN 3.5K
  • Earning Date
  • RFL 03-12-2025
  • BAFN 01-30-2025
  • Dividend Yield
  • RFL N/A
  • BAFN 2.33%
  • EPS Growth
  • RFL N/A
  • BAFN N/A
  • EPS
  • RFL N/A
  • BAFN 0.72
  • Revenue
  • RFL $697,000.00
  • BAFN $76,217,000.00
  • Revenue This Year
  • RFL N/A
  • BAFN N/A
  • Revenue Next Year
  • RFL N/A
  • BAFN N/A
  • P/E Ratio
  • RFL N/A
  • BAFN $18.67
  • Revenue Growth
  • RFL 151.62
  • BAFN 7.06
  • 52 Week Low
  • RFL $1.29
  • BAFN $10.40
  • 52 Week High
  • RFL $2.50
  • BAFN $15.05
  • Technical
  • Relative Strength Index (RSI)
  • RFL 58.35
  • BAFN 58.58
  • Support Level
  • RFL $1.83
  • BAFN $13.07
  • Resistance Level
  • RFL $2.01
  • BAFN $13.40
  • Average True Range (ATR)
  • RFL 0.15
  • BAFN 0.39
  • MACD
  • RFL 0.02
  • BAFN 0.03
  • Stochastic Oscillator
  • RFL 94.44
  • BAFN 99.99

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a one bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios.

Share on Social Networks: